1 Product identity
Ingredient risk
Not yet assessed

Serretia 250,000 SPUs

BrandArthur Andrew Medical→Non-Nutrient/Non-Botanical Capsule 2 ingredients DSLD #21307
Net contents: 60 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-06-25
2 Ingredients (2)
IngredientGroupSafety
SerrapeptaseSerratiopeptidase—
CelluloseCellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Serrapeptase — Limited Evidence
⚠ Increased bleeding risk
⚠ Lung inflammation (rare)
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID21307
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-06-25
6 More from Arthur Andrew Medical
View Arthur Andrew Medical Safety Scorecard → 4 products
Nattovena - Pure NattokinaseSerretia - Pure SerrapeptaseSerretia 250,000 SPUs
7 Cite this page
Vancouver
Pkhakadze G. Serretia 250,000 SPUs — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 27]. Available from: https://supplement.ge/products/dsld-21307/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG